ZFIN All Figures, Chen <i>et al.</i>, 2016

Chen et al., 2016

ZDB-PUB-161016-7
PMID:27740776
Fig. 8
Fig. 9

FIGURE SUMMARY

Title: Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease
Authors: Chen, T., Li, C., Li, Y., Xiang, Y., Lee, S.M., Zheng, Y.
Source: Full text @ Mol. Pharm.

Fig. 8

ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

PHENOTYPE:

Fish:	WT
Conditions:	chemical treatment by environment: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine chemical treatment by environment: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Observed In:	locomotory behavior
Stage:	Protruding-mouth

Phenotype details

Fig. 9

PHENOTYPE:

Fish:	WT
Conditions:	chemical treatment by environment: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine chemical treatment by environment: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Observed In:	diencephalon dopaminergic neuron
Stage:	Protruding-mouth

Phenotype details

Acknowledgments

Full text @ Mol. Pharm.

Chen et al., 2016 ZDB-PUB-161016-7 PMID:27740776

Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease

Chen et al., 2016

ZDB-PUB-161016-7
PMID:27740776